N/A
N=60
Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)
Intimate Partner Violence · Self-efficacy
Bottom Line
View on ClinicalTrials.gov: NCT03261700 ↗Enrolled (actual)
60
Serious AEs
8.3%
Results posted
Mar 2023
Primary outcome: Primary: Empowerment Via the Personal Progress Scale Revised — 129.82; 132.25; 146.13; 137.24 score on a scale — p=<.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- RISE (Behavioral); Information and referral condition (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- VA Office of Research and Development
- Primary completion
- Nov 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Empowerment Via the Personal Progress Scale Revised |
129.82; 132.25; 146.13; 137.24; 148.07; 137.66 | <.05 sig |
| PRIMARY Self-efficacy Via the General Self-Efficacy Scale |
28.7; 29.90; 33.33; 30.66; 34.07; 30.52 | <.05 sig |
| PRIMARY Valued Living Questionnaire |
49.88; 48.88; 63.27; 53.44; 60.96; 57.23 | — |
| PRIMARY Patient Activation Measure (PAM-13) |
65.89; 64.62; 76.5; 69.24; 75.5; 70.12 | — |
| SECONDARY PTSD Checklist for DSM-5 |
41.92; 39.97; 29.97; 36.97; 32.73; 32.13 | — |
| SECONDARY Center for Epidemiological Studies-Depression Scale |
27.21; 24.50; 19.59; 22.76; 21.12; 19.72 | — |
| SECONDARY SF-12 Health Survey |
3; 3; 3; 2; 3; 3 | — |
| SECONDARY Conflict Tactic Scales Revised |
11.17; 11.67; 3.37; 4.93; 3.34; 2.8 | — |
| SECONDARY Physical, Mental and Social Service Care Use |
8.27; 7.03; 6.15; 6.24; 4.62; 4.93 | — |
| SECONDARY Client Services Questionnaire (CSQ-8) |
29.30; 25.07 | — |
| SECONDARY Patient Health Questionnaire |
12.52; 10.60; 11.37; 12.01; 11.42; 9.69 | — |
| SECONDARY Safety Behaviors Checklist |
12.87; 12.94; 13.04; 12.39; 9.4; 12.34 | — |
| SECONDARY Connor-Davidson Resilience Scale |
25.43; 24.1; 29.67; 26; 29.65; 26.07 | — |
| SECONDARY Depression Anxiety Stress Scale- Anxiety Subscale |
25.11; 23.4; 22.67; 22.98; 23.58; 21.22 | — |
| SECONDARY Coping Strategies Inventory - Short Form |
26.42; 25.69; 27.30; 25.74; 26.92; 25.4 | — |
| SECONDARY Brief Semi-structured Interview to Assess Acceptability and Feasibility of the Intervention, With Perceived Helpfulness Rating. |
23; 16; 6; 14; 0; 0 | — |
Summary
Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases detection of IPV, less is established about how to intervene following IPV disclosure in health care settings, in order to improve health outcomes. Existing healthcare-based interventions result in minimal effects on health and well-being, likely because they are too brief and generic.
In response, the PI has developed Recovering from IPV through Strengths and Empowerment (RISE), based on the IPV-related health care needs and preferences of women Veterans. RISE is designed to be delivered in primary care and is an individualized, variable-length, modular-based intervention that addresses
* safety planning;
* education on the health effects of IPV and warning signs;
* increasing coping skills and self-care;
* enhancing social support;
* making difficult decisions; and
* connecting with resources. This study is aimed at refining and evaluating RISE for use with female VA patients who have experienced past-year IPV. This brief counseling intervention is intended to be administered in conjunction with primary care, as this is a frequent point of healthcare contact for women Veterans and where disclosure of IPV is most prevalent.
Eligibility Criteria
Inclusion Criteria
Participants will be eligible to participate if they:
- Self-identify as a woman
- Are at least 18 years of age
- A patient at VA Boston Healthcare System
- Self- reported that they have experienced past-year physical, sexual, or psychological IPV
- Ability to understand study procedures in English
- Not exhibiting symptoms of mania or psychosis
- Not actively in suicidal crisis warranting imminent hospitalization
Exclusion Criteria
- Any violation of inclusion criteria
Data sourced from ClinicalTrials.gov (NCT03261700). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.